With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S.

Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...

Embrace Gynecology becomes the third IDE clinical study for Hugo RAS in the U.S., demonstrating Medtronic’s commitment to ...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their ...

It's a major specialist in robotic surgery equipment, boasting more than 16 million procedures performed on its equipment and ...

The growth of surgical robots is huge, and this company is looking to get in on the action while it also works to boost its ...

Nearly 60 of the state’s biggest companies showcased their latest innovations, historical artifacts or community impact ...

Surgical robotics is not a new phenomenon, but it's a space that continues to foster innovation across a range of ...

In Operating Room 9 on Friday, Freeman Health System neurosurgeons introduced two technologies for spinal surgeries where precision is key. The neurosurgeons said Freeman is the only hospital system ...

Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating.

AIIMS Delhi inaugurates the da Vinci Surgical Robot at its SET facility, becoming India’s first govt institute to offer dual robotic surgery training, boosting surgical skills and patient safety.